IPO registrations (S-1, F-1) · Registrants
Aevi Genomic Medicine, LLC
- SEC CIK
- 1138776 · filings on EDGAR ↗
- Name on the registration
- MEDGENICS, INC.
- Former names
- Aevi Genomic Medicine, Inc. (2016–2020); MEDGENICS, INC. (2009–2016); MEDGENICS INC (2003–2006)
- Registration
- Form S-1, first filed 2010-11-05, last 2011-04-05; 1 initial registration, 11 amendments
- Outcome
- Final prospectus filed 2011-04-11; declared effective 2011-04-07
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 435 DEVON PARK DRIVE,, SUITE 715, Wayne, PA 19087
- EIN
- 98-0217544
- EDGAR entity type
- operating
- Insiders and CEO pay
- Aevi Genomic Medicine, LLC on the corporate pages
Offering terms
- Final price
- $4.54 per share (424B1 filed 2011-04-11, an initial public offering)
- Shares sold
- 2,460,000
- Gross proceeds
- $11,168,400 before underwriting discounts and any over-allotment option
- Listing
- NYSE American under the symbol MDGN
- Lead underwriters
- Roth Capital Partners
- Syndicate
- Maxim Group
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: AEVI GENOMIC MEDICINE, INC. EXACT (EIN (EXACT))
- Form D issuer: Aevi Genomic Medicine, Inc. EXACT (CIK (EXACT))
- SEC filer: Aevi Genomic Medicine, Inc. EXACT (CIK (EXACT))
- Person page: Joel S Kanter Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Joseph J Grano Jr Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Wilbur H Gantz Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 17
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-11-05 | S-1 | S-1 (registration) | MEDGENICS, INC. | 0001144204-10-058022 ↗ |
| 2010-12-16 | S-1/A | S-1/A (amendment) | MEDGENICS, INC. | 0001144204-10-066748 ↗ |
| 2011-01-11 | S-1/A | S-1/A (amendment) | MEDGENICS, INC. | 0001144204-11-001763 ↗ |
| 2011-02-17 | S-1/A | S-1/A (amendment) | MEDGENICS, INC. | 0001144204-11-009445 ↗ |
| 2011-02-22 | S-1/A | S-1/A (amendment) | MEDGENICS, INC. | 0001144204-11-010019 ↗ |
| 2011-02-24 | S-1/A | S-1/A (amendment) | MEDGENICS, INC. | 0001144204-11-010566 ↗ |
| 2011-02-25 | S-1/A | S-1/A (amendment) | MEDGENICS, INC. | 0001144204-11-010895 ↗ |
| 2011-03-25 | S-1/A | S-1/A (amendment) | MEDGENICS, INC. | 0001144204-11-017209 ↗ |
| 2011-03-29 | S-1/A | S-1/A (amendment) | MEDGENICS, INC. | 0001144204-11-017900 ↗ |
| 2011-04-04 | S-1/A | S-1/A (amendment) | MEDGENICS, INC. | 0001144204-11-019888 ↗ |
| 2011-04-05 | S-1/A | S-1/A (amendment) | MEDGENICS, INC. | 0001144204-11-020076 ↗ |
| 2011-04-05 | S-1/A | S-1/A (amendment) | MEDGENICS, INC. | 0001144204-11-020228 ↗ |
| 2011-04-07 | EFFECT | EFFECT (declared effective) | MEDGENICS, INC. | 9999999995-11-000912 ↗ |
| 2011-04-11 | 424B1 | 424B1 (final prospectus) | MEDGENICS, INC. | 0001144204-11-021200 ↗ |
| 2012-07-20 | EFFECT | EFFECT (declared effective) | MEDGENICS, INC. | 9999999995-12-002215 ↗ |
| 2012-08-02 | EFFECT | EFFECT (declared effective) | MEDGENICS, INC. | 9999999995-12-002363 ↗ |
| 2012-10-26 | EFFECT | EFFECT (declared effective) | MEDGENICS, INC. | 9999999995-12-003096 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2011-04-05 | S-1/A | registration statement | 2,500,000 | - | NYSE American MDGN | 2 | primary document; shares headline, cover names 2 | document ↗ | ||
| 2011-04-11 | 424B1 | final prospectus | $4.54 | 2,460,000 | $11,168,400 | NYSE American MDGN | 2 | primary document; price sentence, shares headline, proceeds computed, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BAUER EUGENE A | Director; Director,Officer | Executive Chairman | 12 | 2011–2020 | |
| Bellin Phyllis K. | Officer | see Remarks; See Remarks | 6 | 2011–2014 | |
| Bellomo Stephen | Officer | Chief Operating Officer; See Remarks | 4 | 2011–2012 | |
| BRUKARDT GARY A | Director | 4 | 2011–2012 | ||
| CHICAGO INVESTMENTS INC | TenPercentOwner | 2 | 2011 | ||
| CLEMOW ALASTAIR J | Director | 14 | 2011–2020 | ||
| Estate of Lord Leonard Steinberg | TenPercentOwner | 2 | 2011 | ||
| KANTER JOEL S | Director | 10 | 2011–2015 | person page Fuzzy | |
| Kanter Joshua | TenPercentOwner | 2 | 2011 | ||
| MCMURRAY STEPHEN D | Director | 10 | 2011–2015 | ||
| Pearlman Andrew | Director; Director,Officer; Officer | President and CEO | 14 | 2011–2014 | |
| River Charitable Remainder Unitrust f/b/o Isaac Blech | TenPercentOwner | 4 | 2011 | ||
| Stern Baruch | Officer | Chief Scientific Officer | 2 | 2011 | |
| BLECH ISAAC | Director; Director,TenPercentOwner; TenPercentOwner | 11 | 2011–2016 | ||
| Liberty Charitable Remainder Trust f/b/o Isaac Blech | Other | 1 | 2011 | ||
| West Charitable Remainder Unitrust | Other | 1 | 2011 | ||
| DELLIO CLARENCE L | Officer | Chief Operating Officer | 7 | 2011–2013 | |
| BARER SOL J | Director | 28 | 2012–2020 | ||
| Garovoy Marvin | Officer | Chief Medical Officer | 2 | 2012 | |
| GRANO JOSEPH J JR | Director | 14 | 2013–2020 | person page Fuzzy | |
| COLA MICHAEL F | Director,Officer | Chief Executive Officer; President and CEO | 16 | 2013–2020 | |
| Leaman John Harold | Officer | Chief Financial Officer | 4 | 2013–2015 | |
| NEIL GARRY ARTHUR | Officer | Chief Scientific Officer; Global Head of R&D | 15 | 2013–2020 | |
| GANTZ WILBUR H | Director | 8 | 2013–2017 | person page Fuzzy | |
| Applebaum Scott | Officer | Chief Legal Officer | 4 | 2014–2016 | |
| Duncan Barbara Gayle | Director | 9 | 2015–2020 | ||
| Piper Brian | Officer | CFO and Corporate Secretary; CFO & Corporate Secretary; Chief Financial Officer | 7 | 2016–2018 | |
| HARPER PHILIP R | TenPercentOwner | 5 | 2017 | ||
| Children's Hospital of Philadelphia Foundation | TenPercentOwner | 3 | 2017–2020 | ||
| Bayley Matthew D | Director | 5 | 2017–2020 | ||
| McInaw Michael | Officer | Interim CFO | 2 | 2019–2020 | |
| ASTRAZENECA PLC | TenPercentOwner | 2 | 2020 | ||
| MedImmune Ltd | TenPercentOwner | 2 | 2020 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-10-19 | Aevi Genomic Medicine, Inc. | Biotechnology | $28,000,000 | $28,000,000 | 12 | 1 |
| 2015-10-15 | MEDGENICS, INC. | Biotechnology | $3,200,000 | $3,200,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | AEVI GENOMIC MEDICINE, INC. | PA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | Aevi Genomic Medicine, Inc. | PA | Form D private offerings | CIK (EXACT) |
| Nonprofit | GOLFBRIDGE SOCIETY | PA | Nonprofits (IRS Form 990) | same street address and ZIP code, 435 DEVON PARK DR STE 715 19087 (FUZZY: a shared address, not proof of a shared organization) |
| SEC filer | Aevi Genomic Medicine, LLC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | AEVI GENOMIC MEDICINE, INC. | PA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | AEVI GENOMIC MEDICINE, INC. | EIN (EXACT) | ||
| Person page | Joel S Kanter | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Joseph J Grano Jr | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Wilbur H Gantz | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), PA first:
- APOLLON INC PA
- Ocugen, Inc. PA
- Spark Therapeutics, Inc. PA
- Krystal Biotech, Inc. PA
- Cabaletta Bio, Inc. PA
- Passage BIO, Inc. PA
- Century Therapeutics, Inc. PA
- Aphton CORP PA
- Aceragen, Inc. PA
- GENAERA CORP PA
In other datasets, the same topic (Health) in PA:
- Nonprofit: 445 FOUNDATION (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health